{
    "2018-06-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Amgen Announces Top-Line Data From Remicade Biosimilar Study",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Top-Line Data",
                        "Remicade",
                        "Biosimilar",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Drug Pricing",
                        "Concerns",
                        "Valuations",
                        "Opportunities"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}